NCT05661942View on ClinicalTrials.gov

Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

November 20, 2024

Study Completion Date

November 20, 2024

Conditions
Atrial Fibrillation With Rapid Ventricular ResponseHypotension Drug-Induced
Interventions
DRUG

Calcium pre-treatment

The intervention is Calcium gluconate 1 gram/100ml 0.9% NaCl or 100ml 0.9% NaCl) over 5 minutes.

OTHER

Placebo

Placebo/ no calcium pre-treatment.

Trial Locations (1)

60453

Advocate Christ Medical Center Emergency Department (ACMC ED), Oak Lawn

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER